Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Discovery Labs Raises $12.8M Privately To Progress Surfaxin

Nov. 7, 2002

By Aaron Lorenzo

Isis Gets Rights To ISIS 14803 Back From Elan Joint Venture

Nov. 7, 2002

By Aaron Lorenzo

Discovery Labs Raises $12.8M Privately To Progress Surfaxin

Nov. 7, 2002

By Aaron Lorenzo

GeoVax Prepares For Trials Of AIDS Vaccine Candidate

Nov. 6, 2002

By Aaron Lorenzo

GeoVax Prepares For Trials Of AIDS Vaccine Candidate

Nov. 6, 2002

By Aaron Lorenzo

Alexion Data Point To Potential For Treatment Over Long Term

Nov. 5, 2002

By Aaron Lorenzo

Alexion Data Point To Potential For Treatment Over Long Term

Nov. 5, 2002

By Aaron Lorenzo

Cerus Gets $50M Loan Pledge From Intercept Partner Baxter

Nov. 1, 2002

By Aaron Lorenzo

Cerus Gets $50M Loan Pledge From Intercept Partner Baxter

Nov. 1, 2002

By Aaron Lorenzo

Neurogenetics Closes Series B With Second Tranche Of $10M

Oct. 31, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...